论文部分内容阅读
目的:观察腹水超滤浓缩回输联合盐水蛋白治疗腹吸水的临床疗效及不良反应。方法:选择肝硬化顽固腹吸水患者20例,试验组:10例,为腹水超滤浓缩回输联合盐水蛋白治疗;对照组:10例,为单纯腹水超滤浓缩回输治疗。结果:两组的腹水均明显消退,试验组更为显著(P<0.05),试验组临床及血清蛋白、肾功能均明显改善,且1个月内无反复。结论:腹水超滤浓缩回输联合盐水蛋白治疗顽固腹吸水疗效显著且安全。
Objective: To observe the clinical efficacy and adverse reactions of ascites ultrafiltration concentrated reinfusion combined with saline solution in the treatment of abdominal water absorption. Methods: Twenty patients with stubborn abdominal water absorption of liver cirrhosis were selected. The experimental group consisted of 10 patients treated by ultrafiltration of ascites and reinfusion combined with saline protein. The control group, 10 patients, were treated by ultrafiltration and ascites infusion alone. Results: The ascites of both groups subsided obviously, and the experimental group was more significant (P <0.05). The clinical and serum protein and renal function of the experimental group were significantly improved, with no recurrence within 1 month. Conclusion: Ascites ultrafiltration concentrated infusion combined with saline protein treatment of stubborn abdominal water absorption significant and safe.